In low-risk patients, the tumor microenvironment is characterized by a substantial infiltration of immune cells, including CD4 T cells and CD8 T cells, which are classified as tumor-infiltrating lymphocytes (TILs), as well as a notable presence of M2 macrophages and DCs. This evidence concerns the gene CD4 and neoplasm.